WEBSITE BSE:508869 NSE : APOLLO HOSP. 26 Dec, 16:01
Market Cap ₹104421 Cr.
Stock P/E 113.9
P/B 12.7
Current Price ₹7262.3
Book Value ₹ 569.6
Face Value 5
52W High ₹7545.1
Dividend Yield 0.22%
52W Low ₹ 5618.3
Apollo Hospitals Enterprise Limited is an India-based organisation, that is engaged in providing complete health facility offerings. The Company affords and sells pharma and well being products via a community of pharmacies. The predominant activities of the Company encompass the operation of multidisciplinary non-public hospitals, clinics and pharmacies. The Company operates via two segments: Healthcare and Retail Pharmacy. The Healthcare section represents hospitals and primarily medical institution-based pharmacies. The Retail Pharmacy section represents the commercial enterprise of procurement and distribution of pharmaceutical, FMCG and private label merchandise. The Company has approximately 10209 beds throughout about 71 Hospitals, 24118 pharmacies in 20 states and four union territories.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
---|---|---|---|---|---|
Net Sales | 1625 | 1650 | 1813 | 1856 | 1863 |
Other Income | 9 | -4 | 3 | 8 | 5 |
Total Income | 1634 | 1647 | 1816 | 1864 | 1869 |
Total Expenditure | 1454 | 1477 | 1592 | 1635 | 1649 |
Operating Profit | 179 | 170 | 224 | 229 | 219 |
Interest | 58 | 55 | 59 | 64 | 62 |
Depreciation | 63 | 65 | 66 | 68 | 73 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 59 | 50 | 99 | 98 | 84 |
Provision for Tax | 10 | 15 | 28 | 30 | 24 |
Profit After Tax | 48 | 35 | 71 | 67 | 60 |
Adjustments | -48 | -35 | -71 | -67 | -60 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share | 3.5 | 2.5 | 5.1 | 4.8 | 4.3 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 3862 | 4593 | 5588 | 6301 | 7183 | 8337 | 9794 | 4654 | 6098 | 6525 | 7274 | 7182 |
Other Income | 22 | 45 | 40 | 48 | 14 | 14 | 18 | 21 | 47 | 152 | 180 | 12 |
Total Income | 3884 | 4638 | 5629 | 6349 | 7197 | 8351 | 9812 | 4675 | 6145 | 6676 | 7454 | 7196 |
Total Expenditure | 3248 | 3915 | 4852 | 5549 | 6355 | 7320 | 8386 | 3945 | 4679 | 4843 | 5476 | 6353 |
Operating Profit | 636 | 723 | 777 | 800 | 842 | 1030 | 1426 | 730 | 1466 | 1833 | 1977 | 842 |
Interest | 87 | 83 | 134 | 200 | 240 | 268 | 426 | 340 | 244 | 239 | 250 | 240 |
Depreciation | 129 | 158 | 201 | 241 | 272 | 300 | 482 | 421 | 363 | 367 | 399 | 272 |
Exceptional Income / Expenses | 0 | -15 | -26 | 0 | 0 | 0 | 164 | -9 | -7 | 0 | 0 | 0 |
Profit Before Tax | 420 | 467 | 417 | 359 | 330 | 463 | 682 | -40 | 852 | 1228 | 1329 | 331 |
Provision for Tax | 89 | 121 | 83 | 74 | 97 | 160 | 212 | -14 | 280 | 143 | 318 | 97 |
Profit After Tax | 331 | 347 | 334 | 285 | 233 | 303 | 470 | -26 | 573 | 1085 | 1011 | 233 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 131 | 93 | 0 | 0 | -233 |
Profit After Adjustments | 331 | 347 | 334 | 285 | 233 | 303 | 470 | 105 | 665 | 1085 | 1011 | 0 |
Adjusted Earnings Per Share | 23.8 | 24.9 | 24 | 20.5 | 16.8 | 21.8 | 33.8 | -1.8 | 39.8 | 75.4 | 70.3 | 16.7 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 11% | 16% | -3% | 7% |
Operating Profit CAGR | 8% | 39% | 14% | 12% |
PAT CAGR | -7% | 0% | 27% | 12% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 29% | 14% | 39% | 20% |
ROE Average | 14% | 14% | 10% | 10% |
ROCE Average | 17% | 16% | 14% | 12% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 2965 | 3161 | 3316 | 3579 | 3693 | 3884 | 3988 | 5202 | 6111 | 6925 | 7711 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1005 | 1461 | 2003 | 2620 | 2547 | 2597 | 2500 | 1965 | 1908 | 1520 | 1786 |
Other Non-Current Liabilities | 332 | 402 | 530 | 938 | 1025 | 1164 | 2681 | 2065 | 2403 | 2594 | 3362 |
Total Current Liabilities | 555 | 796 | 989 | 750 | 1315 | 1633 | 1943 | 1521 | 1189 | 1243 | 1370 |
Total Liabilities | 4857 | 5820 | 6838 | 7888 | 8581 | 9278 | 11112 | 10753 | 11611 | 12282 | 14229 |
Fixed Assets | 1989 | 2428 | 3061 | 3600 | 3762 | 3970 | 6056 | 5038 | 5121 | 5078 | 6032 |
Other Non-Current Assets | 1510 | 1696 | 2067 | 2543 | 2840 | 3305 | 2741 | 2678 | 3035 | 4054 | 4522 |
Total Current Assets | 1358 | 1696 | 1710 | 1744 | 1980 | 2003 | 2315 | 3038 | 3455 | 3151 | 3675 |
Total Assets | 4857 | 5820 | 6838 | 7888 | 8581 | 9278 | 11112 | 10753 | 11611 | 12282 | 14229 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 255 | 209 | 249 | 235 | 192 | 247 | 219 | 281 | 239 | 360 | 217 |
Cash Flow from Operating Activities | 303 | 389 | 626 | 632 | 539 | 907 | 1096 | 915 | 1201 | 1225 | 1191 |
Cash Flow from Investing Activities | -310 | -681 | -910 | -804 | -378 | -776 | -264 | -765 | -505 | -589 | -835 |
Cash Flow from Financing Activities | -40 | 332 | 290 | 130 | -106 | -160 | -771 | -176 | -577 | -779 | -297 |
Net Cash Inflow / Outflow | -47 | 40 | 7 | -43 | 54 | -28 | 62 | -25 | 119 | -143 | 59 |
Closing Cash & Cash Equivalent | 209 | 249 | 256 | 192 | 247 | 219 | 281 | 239 | 360 | 217 | 276 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 23.77 | 24.91 | 24 | 20.5 | 16.76 | 21.75 | 33.78 | -1.84 | 39.81 | 75.44 | 70.27 |
CEPS(Rs) | 33.05 | 36.27 | 38.41 | 37.79 | 36.31 | 43.3 | 68.43 | 27.46 | 65.08 | 100.94 | 98.02 |
DPS(Rs) | 5.75 | 5.75 | 6 | 6 | 5 | 6 | 6 | 3 | 11.75 | 15 | 16 |
Book NAV/Share(Rs) | 213.1 | 227.21 | 238.31 | 257.25 | 265.48 | 278.99 | 286.52 | 361.72 | 424.94 | 481.56 | 536.22 |
Core EBITDA Margin(%) | 15.9 | 14.76 | 13.18 | 11.94 | 11.53 | 12.19 | 14.38 | 15.23 | 23.28 | 25.77 | 24.71 |
EBIT Margin(%) | 13.14 | 11.99 | 9.85 | 8.88 | 7.94 | 8.76 | 11.31 | 6.44 | 17.98 | 22.47 | 21.7 |
Pre Tax Margin(%) | 10.88 | 10.18 | 7.46 | 5.7 | 4.6 | 5.55 | 6.97 | -0.87 | 13.98 | 18.81 | 18.27 |
PAT Margin (%) | 8.56 | 7.55 | 5.98 | 4.53 | 3.25 | 3.63 | 4.8 | -0.57 | 9.39 | 16.63 | 13.89 |
Cash Profit Margin (%) | 11.91 | 10.99 | 9.56 | 8.34 | 7.03 | 7.23 | 9.72 | 8.49 | 15.35 | 22.25 | 19.38 |
ROA(%) | 7.18 | 6.49 | 5.28 | 3.87 | 2.83 | 3.39 | 4.61 | -0.24 | 5.12 | 9.08 | 7.62 |
ROE(%) | 11.62 | 11.32 | 10.31 | 8.27 | 6.41 | 7.99 | 11.95 | -0.57 | 10.12 | 16.64 | 13.81 |
ROCE(%) | 13.11 | 12.39 | 10.49 | 9.32 | 8.76 | 10.58 | 15.53 | 4.1 | 14.04 | 17.43 | 17.2 |
Receivable days | 42.3 | 40.45 | 35.78 | 35.04 | 35.91 | 36.32 | 34.94 | 85.1 | 60.7 | 45.99 | 40.85 |
Inventory Days | 22.23 | 23.74 | 23.31 | 23.86 | 24.93 | 24.08 | 23.64 | 35.99 | 10.69 | 6.86 | 5.44 |
Payable days | 38.75 | 42.83 | 45.95 | 43.04 | 41.55 | 42.18 | 44.51 | 235.4 | 142.16 | 126.12 | 126.94 |
PER(x) | 38.53 | 54.81 | 55.18 | 56.92 | 63.4 | 56.13 | 33.69 | 0 | 113.44 | 57.13 | 90.39 |
Price/Book(x) | 4.3 | 6.01 | 5.56 | 4.54 | 4 | 4.38 | 3.97 | 8.03 | 10.63 | 8.95 | 11.85 |
Dividend Yield(%) | 0.63 | 0.42 | 0.45 | 0.51 | 0.47 | 0.49 | 0.53 | 0.1 | 0.26 | 0.35 | 0.25 |
EV/Net Sales(x) | 3.53 | 4.45 | 3.67 | 2.97 | 2.43 | 2.39 | 1.9 | 9.37 | 10.89 | 9.72 | 12.78 |
EV/Core EBITDA(x) | 21.39 | 28.24 | 26.41 | 23.4 | 20.75 | 19.37 | 13.08 | 59.75 | 45.29 | 34.59 | 47.01 |
Net Sales Growth(%) | 16.39 | 18.93 | 21.68 | 12.76 | 13.99 | 16.06 | 17.49 | -52.48 | 31.04 | 6.99 | 11.48 |
EBIT Growth(%) | 5.54 | 8.55 | 0.01 | 1.57 | 1.97 | 28.09 | 51.7 | -72.97 | 265.92 | 33.75 | 7.65 |
PAT Growth(%) | 6.99 | 4.8 | -3.65 | -14.61 | -18.22 | 29.85 | 55.28 | -105.61 | 2268.56 | 89.48 | -6.85 |
EPS Growth(%) | 6.99 | 4.8 | -3.65 | -14.61 | -18.22 | 29.78 | 55.28 | -105.44 | 2268.54 | 89.48 | -6.85 |
Debt/Equity(x) | 0.36 | 0.53 | 0.71 | 0.77 | 0.81 | 0.83 | 0.79 | 0.44 | 0.33 | 0.25 | 0.25 |
Current Ratio(x) | 2.45 | 2.13 | 1.73 | 2.32 | 1.51 | 1.23 | 1.19 | 2 | 2.91 | 2.53 | 2.68 |
Quick Ratio(x) | 1.97 | 1.71 | 1.34 | 1.74 | 1.1 | 0.88 | 0.83 | 1.86 | 2.78 | 2.46 | 2.6 |
Interest Cover(x) | 5.83 | 6.61 | 4.12 | 2.79 | 2.37 | 2.73 | 2.6 | 0.88 | 4.49 | 6.14 | 6.32 |
Total Debt/Mcap(x) | 0.08 | 0.09 | 0.13 | 0.17 | 0.2 | 0.19 | 0.2 | 0.05 | 0.03 | 0.03 | 0.02 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 29.33 | 29.33 | 29.33 | 29.33 | 29.33 | 29.33 | 29.33 | 29.33 | 29.33 | 29.33 |
FII | 48.48 | 49.09 | 47.94 | 46.96 | 47.93 | 46.15 | 46.25 | 45.63 | 43.92 | 45.37 |
DII | 15.86 | 15.51 | 16.78 | 17.99 | 17.24 | 18.83 | 19.1 | 19.77 | 21.37 | 20.18 |
Public | 6.32 | 6.07 | 5.94 | 5.71 | 5.5 | 5.69 | 5.32 | 5.26 | 5.38 | 5.12 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 |
FII | 6.97 | 7.06 | 6.89 | 6.75 | 6.89 | 6.64 | 6.65 | 6.56 | 6.32 | 6.52 |
DII | 2.28 | 2.23 | 2.41 | 2.59 | 2.48 | 2.71 | 2.75 | 2.84 | 3.07 | 2.9 |
Public | 0.91 | 0.87 | 0.85 | 0.82 | 0.79 | 0.82 | 0.76 | 0.76 | 0.77 | 0.74 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 | 14.38 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About